Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial.

Chambers ES, Byrne CS, Morrison DJ, Murphy KG, Preston T, Tedford C, Garcia-Perez I, Fountana S, Serrano-Contreras JI, Holmes E, Reynolds CJ, Roberts JF, Boyton RJ, Altmann DM, McDonald JAK, Marchesi JR, Akbar AN, Riddell NE, Wallis GA, Frost GS. · 2019

Read Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial. by Chambers ES, Byrne CS, Morrison DJ, Murphy KG, Preston T, Tedford C, Garcia-Perez I, Fountana S, Serrano-Contreras JI, Holmes E, Reynolds CJ, Roberts JF, Boyton RJ, Altmann DM, McDonald JAK, Marchesi JR, Akbar AN, Riddell NE, Wallis GA, Frost GS. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6691855.txt.

Introduction

Chambers and co-authors run a randomised cross-over trial of inulin-propionate ester and inulin. Their trial report appears in Gut. Twelve adults with overweight or obesity took part. None had diabetes at entry. Each received three supplements in turn. The ester delivers propionate selectively to the colon. Plain inulin served as the fermentable control. Cellulose was the low-fermentable comparator. Periods lasted 42 days at 20 grams daily.

Both active fibres improved insulin resistance. Scores beat cellulose clearly for each. The two active arms did not differ. Their other effects diverged, though. The ester lowered interleukin-8 levels. Inulin shifted gut bacteria instead. Actinobacteria rose and Clostridia fell. Propionate targeting may suit selected patients.

Catalog record

CREATORChambers ES, Byrne CS, Morrison DJ, Murphy KG, Preston T, Tedford C, Garcia-Perez I, Fountana S, Serrano-Contreras JI, Holmes E, Reynolds CJ, Roberts JF, Boyton RJ, Altmann DM, McDonald JAK, Marchesi JR, Akbar AN, Riddell NE, Wallis GA, Frost GS.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6691855

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial By Edward S Chambers, Claire S Byrne, Douglas J Morrison, Kevin G Murphy, Tom Preston, Catriona Tedford, Isabel Garcia-Perez, Sofia Fountana, Jose Ivan Serrano-Contreras, Elaine Holmes, Catherine J Reynolds, Jordie F Roberts Published in: Gut DOI: 10.1136/gutjnl-2019-318424 ABSTRACT Abstract Objective To investigate the underlying mechanisms behind changes in glucose homeostasis with delivery of propionate to the human colon by comprehensive and coordinated analysis of gut bacterial composition, plasma metabolome and immune responses. Design Twelve non-diabetic adults with overweight and obesity received 20 g/day of inulin-propionate ester (IPE), designed to selectively deliver propionate to the colon, a high-fermentable fibre control (inulin) and a low-fermentable fibre control (cellulose) in a randomised, double-blind, placebo-controlled, cross-over design. Outcome measurements of metabolic responses, inflammatory markers and gut bacterial composition were analysed at the end of each 42-day supplementation period. Results Both IPE and inulin supplementation improved insulin resistance compared with cellulose supplementation, measured by homeostatic model assessment 2 (mean±SEM 1.23±0.17 IPE vs 1.59±0.17 cellulose, p=0.001; 1.17±0.15 inulin vs 1.59±0.17 cellulose, p=0.009), with no differences between IPE and inulin (p=0.272). Fasting insulin was only associated positively with plasma tyrosine and negatively with plasma glycine following inulin supplementation. IPE supplementation decreased proinflammatory interleukin-8 levels compared with cellulose, while inulin had no impact on the systemic inflammatory markers studied. Inulin promoted changes in gut bacterial populations at the class level (increased Actinobacteria and decreased Clostridia) and order level (decreased Clostridiales) compared with cellulose, with small differences at the species level observed between IPE and cellulose. Conclusion These data demonstrate a distinctive physiological impact of raising colonic propionate delivery in humans, as improvements in insulin sensitivity promoted by IPE and inulin were accompanied with different effects on the plasma metabolome, gut bacterial populations and markers of systemic inflammation. Keywords: short-chain fatty acids, glucose metabolism, colonic microflora, inflammation Significance of this studyWhat is already known on this subject?Short-chain fatty acids (SCFA), derived from fermentation of dietary fibre by the gut microbiota, have been shown to improve host insulin sensitivity.We have previously shown that supplementing the diet with inulin-propionate ester (IPE), designed to deliver the SCFA propionate to the colon, improves glucose homeostasis in humans, but the underlying mechanisms are unclear. Significance of this studyWhat are the new findings?Dietary supplementation with 20 g/day of IPE or the high-fermentable control fibre inulin for 42 days improved insulin sensitivity compared with the low-fermentable fibre control cellulose in adults with overweight and obesity. There were no differences with IPE compared with inulin.Fasting insulin following each supplementation period was associated with different plasma metabolome profiles. A positive association between plasma N-acetyl glycoproteins and fasting insulin was observed following cellulose supplementation, which was not found after inulin or IPE supplementation. Tyrosine (positively) and glycine (negatively) were only associated with fasting insulin following inulin supplementation.The improvement in metabolic health with IPE relative to cellulose supplementation was accompanied with decreased proinflammatory interleukin-8 (IL-8) levels. Analysis in vitro found that peripheral blood mononuclear cells isolated from healthy humans secrete less IL-8 in media containing sodium propionate compared with both sodium acetate and sodium chloride.IPE supplementation caused changes in gut bacterial populations compared with cellulose only at the species level. Inulin supplementation changed gut bacterial composition at both the class and order level, relative to cellulose, and promoted a bifidogenic effect.How might it impact on clinical practice in the foreseeable future?Strategies that promote colonic propionate production may represent a more targeted route to improve glucose homeostasis in individual patients, depending on the underlying mechanisms contributing to the metabolic disorder. INTRODUCTION In both epidemiological studies and randomised controlled trials, higher intakes of dietary fibre are associated with a reduced risk of type 2 diabetes.1 An improvement in metabolic health risk factors is greatest when dietary fibre intake exceeds 25 g/day,1 however, at the population level, average intakes are considerably below this amount.2 Understanding the mechanisms by which increased dietary fibre intake exerts health benefits may allow us to exploit them to prevent or treat metabolic disease. Dietary fibre intake modulates the composition and activity of the gut microbiota.3 An improvement in whole-body insulin sensitivity following increased dietary fibre intake has been linked to increased colonic production of the short-chain fatty acid (SCFA) acetate, propionate and butyrate, the major end products of dietary fibre fermentation by the gut bacteria.4 5 Evidence in human trials has shown that increasing dietary fibre intake protects against weight gain6 7 and improves markers of insulin sensitivity.8–10 These positive effects have been observed with a number of dietary fibre supplements, including whole-grain diets,10 resistant starches9 and inulin-type fructans,8 which produce varying amounts of SCFAs in the gut owing to the complex interaction between the physicochemical properties of the substrate and the gut microbiota.5 11 SCFAs have been suggested to improve insulin sensitivity via effects on metabolic pathways and receptor-mediated mechanisms at various tissue and organ sites.12 Specifically, SCFAs act as ligands for G-protein-coupled receptors (GPR) free fatty acid receptor 2 (FFAR2), FFAR3 and GPR109a, which are expressed throughout the body and have been shown to modulate energy homeostasis.13 Our previous work has primarily focused on the role of the SCFA propionate, as a number of studies have shown that mice receiving a gut microbial transplant that promotes caecal propionate production have improved body composition and glycaemic control.14 15 We have described how inulin-propionate ester (IPE) can target delivery of propionate to the colon,16 17 and observed that long-term ingestion of 10 g/day IPE ameliorates body weight gain and the development of abdominal visceral adipose tissue in overweight human adults.16 A secondary outcome of this study was the observation that IPE improved glucose homeostasis, which was associated with a direct action of propionate on human islet β-cells.18 These studies indicated in vitro that FFAR2 is expressed in human islets and that propionate-mediated signalling potentiated glucose-stimulated insulin release and protected from apoptotic stimuli.18 Long-term colonic propionate delivery also reduced levels of non-esterified fatty acid (NEFA),18 a recognised factor that contributes to β-cell dysfunction and peripheral insulin resistance.19 The stimulation of FFAR2 expressed on adipocytes has previously been shown to inhibit adipocyte lipolysis and the levels of circulating NEFA.20 Insulin-resistant states that develop with increasing adiposity have been linked to the activation of inflammatory responses in different organ sites, including adipose tissue, liver and skeletal muscle, which increases secretion and systemic levels of proinflammatory cytokines.21 It is recognised that increased dietary fibre intake and SCFA production have a profound effect on inflammatory and immune function in the colon, largely through effects on the generation of regulatory T cells (Treg)22 23 and mucosal secretion of IgA.24 Previous work highlights that SCFAs can also influence inflammatory and immune responses beyond their site of production in peripheral tissues.24–26 Supplementing naïve T cell cultures with propionate enhanced Treg development and reduced the expansion of inflammatory Th17 cells.26 The improvements in glucose homeostasis we have previously observed following long-term colonic propionate delivery may be partly explained by a dampening of the low-grade systemic inflammation that accompanies obesity. Although there is increasing evidence that gut bacteria play a role in insulin resistance, the

Read the complete text